US Executive Compensation Proxy SEC Filings β March 16, 2026
Across 43 DEF 14A filings dominated by 2026 proxy statements, overarching themes include robust 2025 financial performance in banks and energy firms (e.g., Trustmark NII +8.4% YoY to $647.2M, Marathon $4.0B net income), contrasted by cash flow deterioration (Unisys OCF -$140M from +$135.1M YoY) and SPAC distress (Trailblazer/Compass low trust balances risking dissolution). Capital returns are strong with $5.2B from Truist (+$10B buyback program), $4.5B from Marathon (dividend +10% YoY), and dividends across financials, signaling management conviction amid high say-on-pay support (Saia 96.9%). Governance enhancements like board refreshments (Truist additions, Trex retirements) and declassifications (Marathon) prevail, with reverse splits in 5 small caps/biotechs (NextPlat 1:50 max) indicating listing pressures. Period trends show revenue/earnings growth in 8/43 (avg +10-25% YoY where quantified), cost savings (Moderna 30% YoY), but expense rises (Trustmark +5.5%). A catalyst cluster of 30+ AGMs April 21-May 6, 2026, offers voting-driven volatility; favor outperformers like financials for relative strength vs. SPACs.